Northwest Biotherapeutics Inc (NWBO) financials · rev $1.3M
Northwest Biotherapeutics Inc (NWBO) rev $1.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.4M | $1.4M |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$59.9M | -$66.5M |
| Net Income | -$60.2M | -$83.8M |
| EPS (Diluted) | $-0.04 | $-0.07 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $26.7M | $27.9M | $31.3M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $2.2M | $2.1M | $7.0M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $105.7M | $74.9M | $136.4M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$44.8M | -$57.0M |
| CapEx | $1.5M | $1.0M |
| Investing Cash Flow | -$1.8M | -$1.0M |
| Financing Cash Flow | $49.3M | $56.8M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $865.0K | $49.0K |
| Free Cash Flow | -$46.3M | -$58.0M |
FAQ
What is NWBO P/E and revenue?
Northwest Biotherapeutics Inc (NWBO) rev $1.3M.
What is NWBO revenue?
Northwest Biotherapeutics Inc last cached revenue is $1.4M (FY2025).
Is NWBO profitable?
Northwest Biotherapeutics Inc last cached net income is -$60.2M.
What are NWBO total assets?
Northwest Biotherapeutics Inc last cached total assets are $26.7M.
What is NWBO free cash flow?
Northwest Biotherapeutics Inc last cached free cash flow is -$46.3M.
Not investment advice. Cached statements, not a live tape.